• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Steamline

Quote






Yeh, but not that exciting due to the lack of a true equity component (company that owns it is private). Typical comp, up to $190-$200k base, may be willing to go a little higher. $50k IC. Oral product. Not sure about management, seems like they may be on your ass. If you have a good situation may not be worth it.
 




















anonymous said:
Still waiting on my offer letter - anyone received one yet? Heard it’s lower then what was originally told…
Click to expand...
Hang on to your old job until you are sure you are comfortable with the culture here. New hires recently told by global senior manager, “I expect 150% and I’m not afraid to fire people”. Probably a bit much for those in the audience on their third day with the company. Same global senior manager is interviewing EVERY new hire for breast product expansion. Be very careful. The leadership team in Europe and the US (led by Egyptian nationals) is painfully unaware of the US healthcare market, post pandemic. They seem to have an outdated Big pharma mindset in a place that is small enough to know everyone by first name and bio. Top leadership is invisible to sales team while making strategy, goals, and comp plans without any input from front line managers. For the sales team working every day, it all appears very disorganized and comes across as extremely disrespectful to everyone on the team. This may ultimately be a great product, but to on the launch team is a short term job, but it’s not a secret that new hires will sacrificial lambs (fired for their mistakes) while they figure this thing out.
 




PersimmonJuice said:
Hang on to your old job until you are sure you are comfortable with the culture here. New hires recently told by global senior manager, “I expect 150% and I’m not afraid to fire people”. Probably a bit much for those in the audience on their third day with the company. Same global senior manager is interviewing EVERY new hire for breast product expansion. Be very careful. The leadership team in Europe and the US (led by Egyptian nationals) is painfully unaware of the US healthcare market, post pandemic. They seem to have an outdated Big pharma mindset in a place that is small enough to know everyone by first name and bio. Top leadership is invisible to sales team while making strategy, goals, and comp plans without any input from front line managers. For the sales team working every day, it all appears very disorganized and comes across as extremely disrespectful to everyone on the team. This may ultimately be a great product, but to on the launch team is a short term job, but it’s not a secret that new hires will sacrificial lambs (fired for their mistakes) while they figure this thing out.
Click to expand...


This company culture sounds eerily like the culture at Puma when everyone was onboarding. Everyone was seasoned and sooo excited and the hits started coming from day 1: car allow was lower than quoted, we were micromanaged by a CEO who had what looked like a hitman running the show for him while looking at every call entered and every expense that went through the acct dept. You had to beg to exhibit at a meeting and we shared one display unit for the entire salesforce until we complained and they sent us each our own. The culture never got any better but the product was a dud from launch. The difference here is that the product has legs.
 




Yes. The Puma comparison sounds valid. This might be the right product, but this definitely isn’t the time to join the organization. The Italians bought Stemline predicated on the potential of 500-1000 cases of BPDCN in the US annually. For 2022, there are less than 100. They view the US sales force and management as completely incompetent, rather than accepting they were sold an empty promise. They probably hired the wrong guys last year to “fix it” (hence the CEO doing the final hiring interviews for the new division). There are some wonderful people at this company who were among those who launched the BPDCN drug. There are dozens and dozens of good people who signed on to the breast expansion without knowing what’s happening here. If it walks like a Puma, and talks like a Puma - it’s a Puma!
 




anonymous said:
Yes. The Puma comparison sounds valid. This might be the right product, but this definitely isn’t the time to join the organization. The Italians bought Stemline predicated on the potential of 500-1000 cases of BPDCN in the US annually. For 2022, there are less than 100. They view the US sales force and management as completely incompetent, rather than accepting they were sold an empty promise. They probably hired the wrong guys last year to “fix it” (hence the CEO doing the final hiring interviews for the new division). There are some wonderful people at this company who were among those who launched the BPDCN drug. There are dozens and dozens of good people who signed on to the breast expansion without knowing what’s happening here. If it walks like a Puma, and talks like a Puma - it’s a Puma!
Click to expand...

What are the initials of the head global person interviewing everyone?
 












So far, they’ve hired one rep for a possible February launch. It is very disorganized and the CEO in Europe is micro-managing the interview process by interviewing all sales candidates. Some people are getting scheduled for final interviews with her on Sunday. Not a good indication of “work/life balance” here
 




anonymous said:
So far, they’ve hired one rep for a possible February launch. It is very disorganized and the CEO in Europe is micro-managing the interview process by interviewing all sales candidates. Some people are getting scheduled for final interviews with her on Sunday. Not a good indication of “work/life balance” here
Click to expand...

Um. Sunday interviews were unlikely as that was CHRISTMAS DAY.. Nice try. Stop spending lies.
 




PersimmonJuice said:
Hang on to your old job until you are sure you are comfortable with the culture here. New hires recently told by global senior manager, “I expect 150% and I’m not afraid to fire people”. Probably a bit much for those in the audience on their third day with the company. Same global senior manager is interviewing EVERY new hire for breast product expansion. Be very careful. The leadership team in Europe and the US (led by Egyptian nationals) is painfully unaware of the US healthcare market, post pandemic. They seem to have an outdated Big pharma mindset in a place that is small enough to know everyone by first name and bio. Top leadership is invisible to sales team while making strategy, goals, and comp plans without any input from front line managers. For the sales team working every day, it all appears very disorganized and comes across as extremely disrespectful to everyone on the team. This may ultimately be a great product, but to on the launch team is a short term job, but it’s not a secret that new hires will sacrificial lambs (fired for their mistakes) while they figure this thing out.
Click to expand...

Sadly, the above is all true. This is a company I would no longer recommend to anyone looking to feel valued.

Pay is OK, but culture has turned 100% toxic. I would pass on any opportunity at Stemline.
 








anonymous said:
Um. Sunday interviews were unlikely as that was CHRISTMAS DAY.. Nice try. Stop spending lies.
Click to expand...

You are 100% incorrect. The CEO EBE based in Europe interviews everyone, often this is on a Sunday. Has ANYONE ever been interviewed by a CEO of a 7 billion dollar YOY enterprise for a sales role?

Get the picture? Mirco....mirco...mirco.....

I'm sorry for those of you starting at Menarini/Stemline it is the worst run oncology company in the US. The Egyptian Nationals referred to on this thread are completely out of their league. Sadly, they were chosen on their religious beliefs.....the biggest no no in corporate America. However, it happened here!

I could go on.....in summary, without a complete shake up in upper management this company is doomed to failure. Good people have been hired to be fired.

If you don't believe this commentary just ask how many senior leaders are left since the Menarini purchase?

All fired, one I was made aware of, the week of Christmas!!!!! Most if not all, outstanding in their roles.
(Don't believe me, ask long term employees)

I will state again, NO ONE in upper management is either qualified or has the business acumen to lead this enterprise. I won't even discuss at length the fact they can't be trusted....not a single word.
 




Ax just fell on the west Heme DM and 3 Heme reps in the East. No notice. Just fired in the same day. Menarini showing their true colors. They care NOTHING about the reps and will fire reps on the spot without warning. Give it a couple months and this will hit the breast team as well. Consider yourself warned and act accordingly.
 












Top Bottom
Back
Quote